ישראל - עברית - Ministry of Health

eliezer linevitz ltd. - mabofloxacine - טבליה - mabofloxacine 20 mg

ישראל - עברית - Ministry of Health

linevitz eliezer - mabofloxacine 20 mg - tablets - treatment of skin and soft tissue infections in dogs caused by susceptible strains of microorganisms. treatment of urinary tract infections in dogs caused by susceptible strains of microorganisms. respiratory tract infections caused by sisceptible strains of microorganisms.

ישראל - עברית - Ministry of Health

eliezer linevitz ltd. - mabofloxacine - טבליה - mabofloxacine 80 mg

ישראל - עברית - Ministry of Health

linevitz eliezer - mabofloxacine 80 mg - tablets - treatment of skin and soft tissue infections in dogs caused by susceptible strains of microorganisms. treatment of urinary tract infections in dogs caused by susceptible strains of microorganisms. respiratory tract infections caused by sisceptible strains of microorganisms.

ישראל - עברית - Ministry of Health

bayer israel ltd - moxifloxacin as hydrochloride - תמיסה לאינפוזיה - moxifloxacin as hydrochloride 1.6 mg/ml - moxifloxacin - moxifloxacin - megaxin iv is indicated for the treatment of adults (> 18 years of age) with community acuired pneumonia caused by streptococcus pneumoniae, haemophilus influenzae, moraxella catarrhalis, staphylococcus aureus, klebsiella pneumoniae, mycoplasma pneumoniae or chlamydia pneumoniae and complicated skin and skin structure infections caused by methicillin susceptible staphylococus aureus, escherichia coli, klebsiella pneumoniae or enterobacter cloacae. appropriate culture and susceptibility tests should be performed before treatment in order to isolate and identify organisms causing infection and to determine their susceptibility to moxifloxacin. therapy with megaxin may be initiated before results of these tests are known; once results become available ,appropriate therapy should be continued.

ישראל - עברית - Ministry of Health

novartis israel ltd - moxifloxacin as hydrochloride - תמיסה לעין - moxifloxacin as hydrochloride 0.5 % - moxifloxacin - moxifloxacin - for the treatment of bacterial conjunctivitis caused by susceptible strains or organisms.

ישראל - עברית - Ministry of Health

bayer israel ltd - moxifloxacin as hydrochloride - טבליות מצופות פילם - moxifloxacin as hydrochloride 0.4 g - moxifloxacin - moxifloxacin - for the treatment of the following bacterial infections: respiratory infections: bronchitis: acute exacerbation of chronic bronchitis ; pneumonia: community acquired ; sinusitis: acute uncomplicated; community-acquired spontaneous and wound infections of the skin and skin structure.

ישראל - עברית - Ministry of Health

bayer israel ltd - moxifloxacin as hydrochloride - טבליות מצופות פילם - moxifloxacin as hydrochloride 0.4 g - moxifloxacin - moxifloxacin - for the treatment of the following bacterial infections: respiratory infections: bronchitis: acute exacerbation of chronic bronchitis ; pneumonia: community acquired ; sinusitis: acute uncomplicated; community-acquired spontaneous and wound infections of the skin and skin structure.

ישראל - עברית - Ministry of Health

bayer israel ltd - moxifloxacin - תמיסה לאינפוזיה - moxifloxacin 400 mg / 250 ml - moxifloxacin - moxifloxacin - megaxin iv is indicated for the treatment of adults (> 18 years of age) with community acuired pneumonia caused by streptococcus pneumoniae, haemophilus influenzae, moraxella catarrhalis, staphylococcus aureus, klebsiella pneumoniae, mycoplasma pneumoniae or chlamydia pneumoniae and complicated skin and skin structure infections caused by methicillin susceptible staphylococus aureus, escherichia coli, klebsiella pneumoniae or enterobacter cloacae. appropriate culture and susceptibility tests should be performed before treatment in order to isolate and identify organisms causing infection and to determine their susceptibility to moxifloxacin. therapy with megaxin may be initiated before results of these tests are known; once results become available ,appropriate therapy should be continued.

ישראל - עברית - Ministry of Health

eliezer linevitz ltd. - marbofloxacin - תמיסה להזרקה - marbofloxacin 100 mg/ml - in cattle: treatment of respiratory infections caused by sensitive strains of pasteurella multocida, pasteurella haemolytica bovis. in sows: treatment of metritis mastitis agalactia syndrome caused by bacterial strains sensitive to marbofloxacin treatment in both species should be given only after the sensitivity of the bacteria has been proven and it has been found that there is no alternative treatment (proven resistance to other agents).